ROTHBLATT MARTINE A

SEC CIK
0001106578

Latest role at each company

Trades

Every Form 4 that lists ROTHBLATT MARTINE A as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
UTHRUNITED THERAPEUTICS CorpSep 25, 20264:31 PM ETSep 24, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$473.5529−$4.5M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 24, 20264:31 PM ETSep 23, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$491.5703−$4.67M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 23, 20264:30 PM ETSep 22, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$494.8264−$4.7M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 22, 20264:33 PM ETSep 21, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$494.5548−$4.7M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 21, 20264:44 PM ETSep 18, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$494.79−$4.7M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 18, 20264:41 PM ETSep 17, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$496.0611−$4.71M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 17, 20264:43 PM ETSep 16, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$501.3865−$4.76M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 16, 20264:35 PM ETSep 15, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$501.5915−$4.77M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 15, 20264:34 PM ETSep 14, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$504.1213−$4.79M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 14, 20264:43 PM ETSep 11, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$500.8182−$4.76M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 11, 20264:34 PM ETSep 10, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$502.3469−$4.77M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 10, 20264:31 PM ETSep 9, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$501.8387−$4.77M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 9, 20264:33 PM ETSep 8, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$499.0311−$4.74M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 8, 20264:31 PM ETSep 4, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$489.1952−$4.65M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 4, 20264:31 PM ETSep 3, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$487.5389−$4.63M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 3, 20264:31 PM ETSep 2, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$493.457−$4.69M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 2, 20264:34 PM ETSep 1, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$514.0884−$4.88M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpSep 1, 20264:33 PM ETAug 31, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$511.0855−$4.86M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 31, 20264:34 PM ETAug 28, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$517.5119−$4.92M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 28, 20264:30 PM ETAug 27, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$522.5659−$4.96M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 27, 20264:34 PM ETAug 26, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$517.2831−$4.91M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 26, 20264:30 PM ETAug 25, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$517.713−$4.92M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 25, 20264:38 PM ETAug 24, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$511.9716−$4.86M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 24, 20264:30 PM ETAug 21, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$518.3859−$4.92M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 21, 20264:44 PM ETAug 20, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$521.0228−$4.95M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 20, 20264:37 PM ETAug 19, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$526.9583−$5.01M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 19, 20264:33 PM ETAug 18, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$515.6022−$4.9M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 18, 20264:31 PM ETAug 17, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$506.5861−$4.81M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 17, 20264:34 PM ETAug 14, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$498.912−$4.74M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 14, 20264:41 PM ETAug 13, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$504.2438−$4.79M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 13, 20265:09 PM ETAug 12, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$515.0261−$4.89M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 12, 20264:30 PM ETAug 11, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$522.8728−$4.97M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 11, 20264:30 PM ETAug 10, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$530.113−$5.04M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 10, 20264:38 PM ETAug 7, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$531.3829−$5.05M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 7, 20264:30 PM ETAug 6, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$525.3551−$4.99M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 6, 20264:34 PM ETAug 5, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$518.7353−$4.93M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 5, 20264:36 PM ETAug 4, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$517.0853−$4.91M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 4, 20264:32 PM ETAug 3, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$516.0599−$4.9M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpAug 3, 20264:32 PM ETJul 31, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$518.9577−$4.93M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 31, 20264:18 PM ETJul 30, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$524.9046−$4.99M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 30, 20267:58 AM ETJul 29, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$522.3671−$4.96M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 28, 20266:19 PM ETJul 28, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$526.7343−$5M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 27, 20269:36 PM ETJul 27, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$530.418−$5.04M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 27, 20266:55 AM ETJul 24, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$531.7388−$5.05M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 24, 20264:30 PM ETJul 23, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$528.581−$5.02M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 23, 20264:36 PM ETJul 22, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$530.5663−$5.04M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 22, 20264:30 PM ETJul 21, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$532.2419−$5.06M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 21, 20264:35 PM ETJul 20, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$531.6879−$5.05M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 20, 20264:32 PM ETJul 17, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$537.0463−$5.1M324.44K−2.8%SEC10b5-1
UTHRUNITED THERAPEUTICS CorpJul 17, 20264:30 PM ETJul 16, 2026ROTHBLATT MARTINE AChairperson & CEOSSaleCommon Stock−9.5K$530.9146−$5.04M324.44K−2.8%SEC10b5-1